IP Library › Granted Patent US 7,399,589
Granted Patent B2
US 7,399,589 · App. 10/735,082 · Granted Jul 15, 2008

Immunological detection of RNA:DNA hybrids on microarrays

Assignee: Digene Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,589
App. No.
10/735,082
Granted
Jul 15, 2008
Kind
B2
Abstract

The present invention provides a hybridization method and kit for the detection and measurement of biological molecules. A test sample containing the biological molecules of interest is hybridized with an unlabeled or optionally a detectably-labeled complementary biomolecule to form a double-stranded hybrid immobilized to a solid phase. The immobilized hybrid may be detected with an entity which specifically recognizes an RNA:DNA hybrid, followed by analyses and quantification. Therefore, the present invention provides a method and kit to detect and measure biological molecules that is simple to use, highly specific, sensitive, and accurate for screening a plurality of biological molecules.

Claims (65)

1. A method for detecting or quantifying a target nucleic acid on a microarray having a plurality of sample detection sites, comprising:

(a) hybridizing the target nucleic acid to a microarray-bound biomolecule probe, forming an immobilized RNA:DNA hybrid;

(b) hybridizing a detectably-labeled biomolecule probe to a non-hybridized portion of the microarray-bound biomolecule probe, forming an immobilized RNA:DNA hybrid complex comprising the target nucleic acid, a detectably-labeled biomolecule probe, and a microarray-bound biomolecule probe;

(c) detecting the target nucleic acid by measuring the immobilized RNA:DNA hybrid complex by binding the complex to a detectable antibody specifically reactive with an RNA:DNA hybrid;

(d) detecting the detectably-labeled biomolecule probe; and

(e) repeating steps (a)–(c) on each of the plurality of sample detection sites, wherein the detectably-labeled biomolecule probe is distinguishable from the detectable antibody.

2. The method according to claim 1 , wherein the repeating steps are carried out sequentially.

3. The method according to claim 1 , wherein the repeating steps are carried out simultaneously.

4. A method for detecting or quantifying a target nucleic acid on a microarray having a plurality of sample detection sites, comprising:

(a) hybridizing a portion of the target nucleic acid to a microarray-bound biomolecule probe, forming an immobilized RNA:DNA hybrid;

(b) hybridizing a non-hybridized portion of the target nucleic acid to a detectably-labeled complementary nucleic acid probe, forming an immobilized RNA:DNA hybrid complex comprising the target nucleic acid, a detectably-labeled biomolecule probe, and a microarray-bound biomolecule probe; and

(c) detecting the target nucleic acid by measuring the immobilized RNA:DNA hybrid complex by binding the complex to a detectable antibody specifically reactive with an RNA:DNA hybrid and the detectably-labeled biomolecule probe; and

(d) repeating steps (a)–(c) on each of the plurality of sample detection sites.

5. The method according to claim 4 , wherein the repeating steps are carried out sequentially.

6. The method according to claim 4 , wherein the repeating steps are carried out simultaneously.

7. A method for detecting or quantifying a target nucleic acid on a microarray having a plurality of sample detection sites, comprising:

(a) hybridizing the target nucleic acid to a complementary nucleic acid probe, forming an RNA:DNA hybrid;

(b) hybridizing a non-hybridized portion of the target nucleic acid to a microarray-bound biomolecule probe, forming an immobilized RNA:DNA hybrid complex comprising the target nucleic acid, a detectably-labeled biomolecule probe, and a microarray-bound biomolecule probe; and

(c) detecting the target nucleic acid by measuring the RNA:DNA hybrid complex by binding the complex to a detectable antibody specifically reactive with an RNA:DNA hybrid; and

(d) repeating steps (a)–(c) on each of the plurality of sample detection sites.

8. The method according to claim 7 , wherein the repeating steps are carried out sequentially.

9. The method according to claim 7 , wherein the repeating steps are carried out simultaneously.

10. A method for detecting or quantifying a target nucleic acid on a microarray having a plurality of sample detection sites, comprising:

(a) hybridizing the target nucleic acid to an immobilized reagent-modified nucleic acid to form an immobilized reagent-modified RNA:DNA hybrid, wherein the immobilized reagent-modified nucleic acid is bound to an immobilized reagent-binding molecule;

(b) detecting the target nucleic acid by measuring the immobilized RNA:DNA hybrid using a detectable antibody specifically reactive with the RNA:DNA hybrid; and

(c) repeating steps

(a)–(b) on each of the plurality of sample detection sites.

11. The method according to claim 10 , wherein the repeating steps are carried out sequentially.

12. The method according to claim 10 , wherein the repeating steps are carried out simultaneously.

13. A method for detecting or quantifying a target nucleic acid on a microarray having a plurality of sample detection sites, comprising:

(a) hybridizing a target nucleic acid to a microarray-bound biomolecule probe, forming an RNA:DNA hybrid;

(b) hybridizing a non-hybridized microarray-bound biomolecule to a complementary region of a detectably-labeled biomolecule probe, wherein said non-hybridized microarray-bound biomolecule probe is different from the microarray-bound biomolecule probe of step (a);

(c) detecting the target nucleic acid by measuring the RNA:DNA hybrid by binding the RNA:DNA hybrid to a detectable antibody specifically reactive with the RNA:DNA hybrid;

(d) detecting the detectably-labeled biomolecule probe; and

(e) repeating steps (a)–(c) on each of the plurality of sample detection sites.

14. The method according to claim 13 , wherein the repeating steps are carried out sequentially.

15. The method according to claim 13 , wherein the repeating steps are carried out simultaneously.

16. A kit for the detection of an RNA:DNA hybrid comprising:

a) a microarray solid support having a plurality of sample detection spots, wherein said sample detection spots are immobilized nucleic acids, said immobilized nucleic acid being complementary to a target nucleic acid or part thereof, or said immobilized nucleic acid being complementary to part of an RNA:DNA hybrid, or said immobilized nucleic acid being complementary to a nucleic acid probe;

b) a hybridization buffer;

c) a wash buffer;

d) a solution comprising an RNase and a detection antibody specifically reactive with an RNA:DNA hybrid; and

e) a biomolecule probe, wherein said probe is a detectably-labeled biomolecule or nucleic acid probe that hybridizes to a portion of the immobilized nucleic acid of (a) but not to that portion complementary to the target nucleic acid, or wherein said probe is a nucleic acid probe complementary to a target nucleic acid.

17. The kit according to claim 16 , wherein the detection antibody is a labeled RNA:DNA hybrid-specific antibody.

18. The kit according to claim 16 , wherein the detection antibody is an RNA:DNA hybrid-specific antibody and a labeled RNA:DNA hybrid antibody-specific antibody.

19. The kit according to claim 17 , wherein the RNA:DNA hybrid-specific antibody is monoclonal.

20. The kit according to claim 18 , wherein the labeled RNA:DNA hybrid antibody-specific antibody is monoclonal.

21. The kit according to claim 17 , wherein the RNA:DNA hybrid-specific antibody is polyclonal.

22. The kit according to claim 18 , wherein the labeled RNA:DNA hybrid antibody-specific antibody is polyclonal.

23. A kit for detecting or quantifying a target nucleic acid on microarray, comprising:

a) a microarray solid support having a plurality of sample detection spots, wherein said sample detection spots are immobilized biomolecule probes complementary to a target nucleic acid or part thereof,

b) a detectably labeled biomolecule probe that hybridizes to a portion of the immobilized biomolecule probe of (a) but not to that portion complementary to the target nucleic acid; and

c) a solution comprising an RNase and a detection antibody specifically reactive with an RNA:DNA hybrid.

24. A kit for detecting or quantifying a target nucleic acid on microarray, comprising:

a) a microarray solid support having a plurality of sample detection spots, wherein said sample detection spots are biomolecule probes complementary to a target nucleic acid;

b) a detectably-labeled nucleic acid probe complementary to a non-hybridized portion of a target nucleic acid that has hybridized to the biomolecule probe of (a); and

c) a solution comprising an RNase and a detection antibody specifically reactive with an RNA:DNA hybrid.

25. A kit for detecting or quantifying a target nucleic acid on microarray, comprising:

a) a nucleic acid probe complementary to a target nucleic acid;

b) a microarray solid support having a plurality of sample detection spots, wherein said sample detection spots are biomolecule probes complementary to a non-hybridized portion of the target nucleic acid after it has hybridized to the nucleic acid probe of (a); and

c) a solution comprising an RNase and a detection antibody specifically reactive with an RNA:DNA hybrid.

26. A kit for detecting or quantifying a target nucleic acid on microarray, comprising:

a) a microarray solid support having a plurality of sample detection spots, wherein said sample detection spots are biomolecule probes complementary to a target nucleic acid and biomolecules complementary to a detectably-labeled biomolecule probe;

b) a detectably-labeled biomolecule probe complementary to a solid-support bound biomolecule of (a); and

c) a solution comprising an RNase and a detection antibody specifically reactive with an RNA:DNA hybrid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2007
From: ZAKEL, JOAN M.; STRANGE, CHRISTINA M.; WILLIAMS, INNA R.; LORINCZ, ATTILA T.; DE LA ROSA, ABEL; LAZAR, JAMES G.
To: DIGENE CORPORATION
Reel/Frame 019356/0381 →
Continuity (4)
Continuation In Part 0970717800 · Nov 6, 2000
Continuation In Part 0944041900 · Nov 15, 1999
Continuation In Part 0902006700 · Feb 6, 1998
Related Publication 20040180362A1 · Sep 16, 2004